Cervomed announces inducement grants under nasdaq listing rule 5635(c)(4)

Boston, dec. 12, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo) (the “company”), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that it has granted equity awards as a material inducement to the employment of two new employees.
CRVO Ratings Summary
CRVO Quant Ranking